NSE – NIFTY 750 | Eris Lifesciences Ltd | 27 Apr 2026

 

INTRODUCTION

This analysis is part of the NIFTY 750 Structural Census, a long-term framework designed to observe price behaviour through structure, classification, and contextual positioning. The objective is to document how price evolves over time without prediction or interpretation bias.

---

STOCK INFORMATION

Table 1

Market	Symbol	Company	Sector
NSE	ERIS	Eris Lifesciences Ltd	Healthcare

Table 2

Market Cap	Dividend Yield	Beta	Face Value
18,816 Cr.	0.54	0.35	1

---

CHART

---

CHART INSIGHT

Structure assessed from earliest reliable data
Base formation → regime shift structure
Showing impulsive behaviour within trend

---

STRUCTURAL STATUS

Structural Classification:
Regime Shift Structure

Context:
Expansion Phase

Table 3

Structural Status	Dominant Regime	Trend Type
Regime Shift Structure	Expansion Phase	Uptrend

---

STRUCTURAL POSITION

Trend: Uptrend
Location: Upper Zone
Behaviour: Impulsive

---

DOMINANT REGIME

The dominant regime is a Expansion Phase within a regime shift structure, characterised by impulsive behaviour.
The current phase is observed from 2023 to present, defining an upper zone.

---

INTERPRETATION

Historical Behaviour
The structure shows an extended decline followed by a prolonged base formation. The earlier phase reflects structural weakness transitioning into accumulation.

Structural Transition
Post-2023, price breaks out of the base, marking a clear regime shift from range-bound behaviour to directional expansion.

Current Structural Behaviour
Price is positioned in the upper zone, continuing to show impulsive behaviour within the emerging trend.

---

INSIGHTS

This structure reflects an ongoing expansion phase following a regime shift from base formation.

---

CONTEXT

This study is part of a broader structural mapping initiative covering the NIFTY 750 universe. The focus remains on identifying how price behaves within established structures across time.

---

DISCLAIMER

This content is for educational purposes only. It is not intended as financial advice or a recommendation to buy or sell any security.

---

FOOTER

EwavesJournal
Structure → Level → Trigger → Probability

TradingView Link: https://www.tradingview.com/chart/ERIS/HzGXRV2G-NSE-NIFTY-750-Eris-Lifesciences-Ltd-27-Apr-2026/

#NF750Census #MarketStructure #ERIS #EwavesJournal